Has incredibly strong INSIDER ownership (look at news).
Only 8 Million in Float with virtually NOBODY owning this at a cost basis above LOW $6's. Could melt up.
Will most likely have record daily volume today. Watching this.
Obviously billions of dollars is the answer to that question.
But is EDAP going to get approved and be the CURE to prostate cancer? If so - the market is not reflecting that fact.
And that is basically the question...
If approved will a LARGE acquirer jump in and grab them and build a huge business based upon EDAP technology?
And one other question....would a possible acquirer make an acquisition PRIOR to an FDA approval?
Simple question - removing all past bias etc.
Assume an approval is granted soon.
What would they be worth to a large medical equipment acquirer?
More than $67 Million? Less than $67 Million?
Price action seems to indicate MAYBE somebody is sniffing around to BUY THEM OUT or somebody seems to think they know SOMETHING here.
Will Sapphire represent 70% + of GTAT revenue by 2015 and beyond?
Will GTAT have $1 Billion Revenues in 2015?
Revenues to $1.5 Billion by 2017?
IF the answer to those is affirmative it would seem that discounting this would arrive at the following price targets:
Year end 2013: $12
Year end 2014: $18
Year End 2015: $25
Year End 2016: $30
GTAT: Prospects of Sapphire Glass Usage Improving in Mobile Industry
If there was one notion GT Advanced Technologies (GTAT) emphasized more heavily than anything else during the 2013 Asia Mobile Expo (May), it’s that the application of sapphires in mobile devices will continue to grow more widespread as the materials’ manufacturing costs go down. The sturdy smartphone display from GTAT, which is composed almost entirely of sapphires, turned out to be one of the biggest exhibition highlights due to the many benefits it promises for future mobile devices.